CORIVAL LIFE SCIENCES

Wockhardt Foundation and Biogetica collabs for multidisciplinary research into Covid-19

Corival Life Sciences has conducted reviews of published ‘in vivo’, ‘in vitro’ and ‘in silica’ research on Covid 19 basis which their first product called ‘Immunofree’ was launched. ‘Immunofree’ is now being entered into a pharma control trial along with reginmune, a product made by Biogetica that has already shown results in herpes trials.